Cargando…
Precision medicine review: rare driver mutations and their biophysical classification
How can biophysical principles help precision medicine identify rare driver mutations? A major tenet of pragmatic approaches to precision oncology and pharmacology is that driver mutations are very frequent. However, frequency is a statistical attribute, not a mechanistic one. Rare mutations can als...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381362/ https://www.ncbi.nlm.nih.gov/pubmed/30610579 http://dx.doi.org/10.1007/s12551-018-0496-2 |
_version_ | 1783396481627062272 |
---|---|
author | Nussinov, Ruth Jang, Hyunbum Tsai, Chung-Jung Cheng, Feixiong |
author_facet | Nussinov, Ruth Jang, Hyunbum Tsai, Chung-Jung Cheng, Feixiong |
author_sort | Nussinov, Ruth |
collection | PubMed |
description | How can biophysical principles help precision medicine identify rare driver mutations? A major tenet of pragmatic approaches to precision oncology and pharmacology is that driver mutations are very frequent. However, frequency is a statistical attribute, not a mechanistic one. Rare mutations can also act through the same mechanism, and as we discuss below, “latent driver” mutations may also follow the same route, with “helper” mutations. Here, we review how biophysics provides mechanistic guidelines that extend precision medicine. We outline principles and strategies, especially focusing on mutations that drive cancer. Biophysics has contributed profoundly to deciphering biological processes. However, driven by data science, precision medicine has skirted some of its major tenets. Data science embodies genomics, tissue- and cell-specific expression levels, making it capable of defining genome- and systems-wide molecular disease signatures. It classifies cancer driver genes/mutations and affected pathways, and its associated protein structural data guide drug discovery. Biophysics complements data science. It considers structures and their heterogeneous ensembles, explains how mutational variants can signal through distinct pathways, and how allo-network drugs can be harnessed. Biophysics clarifies how one mutation—frequent or rare—can affect multiple phenotypic traits by populating conformations that favor interactions with other network modules. It also suggests how to identify such mutations and their signaling consequences. Biophysics offers principles and strategies that can help precision medicine push the boundaries to transform our insight into biological processes and the practice of personalized medicine. By contrast, “phenotypic drug discovery,” which capitalizes on physiological cellular conditions and first-in-class drug discovery, may not capture the proper molecular variant. This is because variants of the same protein can express more than one phenotype, and a phenotype can be encoded by several variants. |
format | Online Article Text |
id | pubmed-6381362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63813622019-03-08 Precision medicine review: rare driver mutations and their biophysical classification Nussinov, Ruth Jang, Hyunbum Tsai, Chung-Jung Cheng, Feixiong Biophys Rev Review How can biophysical principles help precision medicine identify rare driver mutations? A major tenet of pragmatic approaches to precision oncology and pharmacology is that driver mutations are very frequent. However, frequency is a statistical attribute, not a mechanistic one. Rare mutations can also act through the same mechanism, and as we discuss below, “latent driver” mutations may also follow the same route, with “helper” mutations. Here, we review how biophysics provides mechanistic guidelines that extend precision medicine. We outline principles and strategies, especially focusing on mutations that drive cancer. Biophysics has contributed profoundly to deciphering biological processes. However, driven by data science, precision medicine has skirted some of its major tenets. Data science embodies genomics, tissue- and cell-specific expression levels, making it capable of defining genome- and systems-wide molecular disease signatures. It classifies cancer driver genes/mutations and affected pathways, and its associated protein structural data guide drug discovery. Biophysics complements data science. It considers structures and their heterogeneous ensembles, explains how mutational variants can signal through distinct pathways, and how allo-network drugs can be harnessed. Biophysics clarifies how one mutation—frequent or rare—can affect multiple phenotypic traits by populating conformations that favor interactions with other network modules. It also suggests how to identify such mutations and their signaling consequences. Biophysics offers principles and strategies that can help precision medicine push the boundaries to transform our insight into biological processes and the practice of personalized medicine. By contrast, “phenotypic drug discovery,” which capitalizes on physiological cellular conditions and first-in-class drug discovery, may not capture the proper molecular variant. This is because variants of the same protein can express more than one phenotype, and a phenotype can be encoded by several variants. Springer Berlin Heidelberg 2019-01-04 /pmc/articles/PMC6381362/ /pubmed/30610579 http://dx.doi.org/10.1007/s12551-018-0496-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Nussinov, Ruth Jang, Hyunbum Tsai, Chung-Jung Cheng, Feixiong Precision medicine review: rare driver mutations and their biophysical classification |
title | Precision medicine review: rare driver mutations and their biophysical classification |
title_full | Precision medicine review: rare driver mutations and their biophysical classification |
title_fullStr | Precision medicine review: rare driver mutations and their biophysical classification |
title_full_unstemmed | Precision medicine review: rare driver mutations and their biophysical classification |
title_short | Precision medicine review: rare driver mutations and their biophysical classification |
title_sort | precision medicine review: rare driver mutations and their biophysical classification |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381362/ https://www.ncbi.nlm.nih.gov/pubmed/30610579 http://dx.doi.org/10.1007/s12551-018-0496-2 |
work_keys_str_mv | AT nussinovruth precisionmedicinereviewraredrivermutationsandtheirbiophysicalclassification AT janghyunbum precisionmedicinereviewraredrivermutationsandtheirbiophysicalclassification AT tsaichungjung precisionmedicinereviewraredrivermutationsandtheirbiophysicalclassification AT chengfeixiong precisionmedicinereviewraredrivermutationsandtheirbiophysicalclassification |